• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Anticardiolipin Antibodies and Obstructive Vascular Events

Research Project

Project/Area Number 11470122
Research Category

Grant-in-Aid for Scientific Research (B).

Allocation TypeSingle-year Grants
Section一般
Research Field 内科学一般
Research InstitutionHOKAIDO UNIVERSITY

Principal Investigator

KOIKE Takao  Hokkaido Univ.Grad.School of Med.Prof., 大学院・医学研究科, 教授 (80146795)

Project Period (FY) 1999 – 2000
Project Status Completed (Fiscal Year 2000)
Budget Amount *help
¥14,200,000 (Direct Cost: ¥14,200,000)
Fiscal Year 2000: ¥6,700,000 (Direct Cost: ¥6,700,000)
Fiscal Year 1999: ¥7,500,000 (Direct Cost: ¥7,500,000)
Keywordsantiphospholipid antibodies / antiphosphlipid syndrome / anticardiolipin anibodies / lupus anticoagulant / thrombosis / arteriosclerosis / β2GPI / β2GPI-deficiency / 流産 / エピトープ / スシドメイン / ランダムペプチドライブラリー / β2グリコプロテインI / β2グリコプロテイン / 立体構造 / エピトープマッピング / ペプチドライブラリー
Research Abstract

Arterial and/or venous thrombosis, recurrent fetal loss and thrombocytopenia are frequently found in patients with antiphospholipid antibodies (anticardiolipin antibodies (aCL) and lupus anticoagulant (LA)). The term antiphospholipid syndrome (APS) has been used to define this set of pathologic features.. Recent evidence suggested that antiphospholipid antibodies may have contributed to the formation of atherosclerotic lesions. In SLE less than 45 years of age, myocardial infarction has been recognized as a major cause of mortality.
I have reported that aCL found in patients with APS are not simply directed to the CL structure, but require the presence of β2-glycoprotein I (β2GPI) for bindng and that the epitopes is expressed by conformational changes occurring when β2GPI interacts with an oxygen-substituted solid surface.
I performed the reserch project, entitled "Anticardiolipin Antibodies and Obstructive Vascular Events" from 1999 to 2001 and obtained the following results ;
1) Presence of anticardiolipin antibodies is risk factors for thrombus formation and atherosclerosis.
2) We discovered the β2GPI-deficient families and named β2GPI-Sapporo.
3) Genetic polymorphysm of β2GPI is influenced on the epitope formation of aCL and on the development of APS

Report

(3 results)
  • 2000 Annual Research Report   Final Research Report Summary
  • 1999 Annual Research Report
  • Research Products

    (31 results)

All Other

All Publications (31 results)

  • [Publications] 小池隆夫: "Plasma tumor necrosis factor levels and the-238^* a promoter polymorphism in patients with antiphospholipid syndrome."Thromb Haemost.. 85. 198-203 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] 小池隆夫: "Association of autoantibodies against the phosphatidyserine-proteronbin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant."Arthritis Rheum.. 43. 1982-1993 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] 小池隆夫: "Antiphospholipid antibodies in arterial thrombosis."Ann.Med.. 32:1. 27-31 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] 小池隆夫: "Coagulation and fibrinolytic acitvities in 2siblings with β2-glycoprotein I deficiency."Blood.. 96:4. 1954-1955 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] 小池隆夫: "β2-blycoprotein I deficiency : prevalence, genetic background and effects on plasma lipoprotein metabolism and hemostasis."Atherosclerosis.. 152. 337-346 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] 小池隆夫: "β2-Glycoprotein I is necessary to inhibit protein C activity by monoclonal anticardiolipin antibodies."Arthritis Rheum.. 42. 167-174 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] 小池隆夫: "In Atherosclerosis and Autoimmunity.Elsevier Science B.V"Oxidized autoantigens in atherosclerosis.. 8 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] 小池隆夫: "Anticardiolipin Antibody, Thrombosis and Atherosclerosis."The Decade of Autoimmunity.. 9 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Koike, T.: "Plasma tumor necrosis factor levels and the-238^* a promoter polymorphism in patients with antiphospholipid syndrome."Thromb Haemost. 85. 198-203 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Koike, T.: "Association of autoantibodies against the phosphatidyserine-proteronbin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant."Arthritis Rheum.. 43. 1982-1993 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Koike T: "Antiphospholipid antibodies in arterial thrombosis."Ann Med. 32 Suppl 1. 27-31 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Koike, T.: "Coagulation and fibrinolytic activities in 2siblings with β2-glycoprotein I deficiency."Blood. 96 : 4. 1954-1955 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Koike, T.: "β2-blycoprotein I deficiency : prevalence, genetic background and effects on plasma lipoprotein metabolism and hemostasis."Atherosclerosis. 152. 337-346 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Koike, T.: "β2-GlycoproteinI is necessary to inhibit protein C activity by monoclonal anticardiolipin antibodies."Arthritis Rheum.. 42. 167-174 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Koike T: "Oxidized autoantigens in atherosclerosis.. Y Shoenfeld, D.Harats, G Wick ed."In Atherosclerosis and Autoimmunity. Elsevier Science B.V.. 8 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Koike T: "Anticardiolipin Antibody, Thrombosis and Atherosclerosis. Y.Shoenfeld ed.in The Decade of Autoimmunity."Elsevier Science B.V.. 9 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] 小池隆夫: "Heterogeneous behavior anti-β2-glycoprotein."J.Rheumatol.. 72:2. 391-397 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] 小池隆夫: "Lytic epstein-barr virus infection in the synovial tissue of patients with rheumatoid arthritis."Arthritis.Rheum.. 43:6. 1218-1225 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] 小池隆夫: "Effects of β2glycoprotein I and monoclonal anticardiolipin antibodies on extrinsic fibrinolysis."Seminars in Thrombosis and Hemostasis.. 26:1. 85-90 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] 小池隆夫: "Proteolytic cleavage of β2-glycoprotein I : reduction of antigenicity and the structual relationship."Internal.Immnol.. 12:8. 1183-1192 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] 小池隆夫: "Cardiac valve diseases and antiphospholipid syndrome."Int.med.. 39:6. 446-447 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] 小池隆夫: "Coagulation and fibrinolytic activities in 2siblings with β2-glycoprotein I deficiency."Blood.. 96:4. 1594-1595 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] 小池隆夫: "免疫症患のとらえかた-眼でみるベットサイドの病態生理-"文光堂. 236 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Ikeo, M.: "β2-GlycoproteinI is necessary to inhibit protein C activity by monoclonal anticardiolipin antibodies"Arthritis & Rheum.. 42:1. 167-174 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Krause, I.: "Anti-idiotype immunomodulation of experimental anti -phospholipid syndrome via effect on Th1/Th2 expression"Clin. Exp. Immunol.. 117. 190-197 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Atsumi, T.: "Correlation between β-2glycoproteinI valine/leucine^<247> polymorphism and anti-β2-glycoproteinI antibodies in patients with primary antiphospholipid syndrome"British Society for Rheumatol.. 38. 721-723 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Haseyama, Y.: "Phosphatidylinositol 3-Kinase is involved in the protection of primary cultured human erythroid precursor cells apoptosis"Blood. 94:5. 1568-1577 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Ichikawa, K.: "T.A chieric antibody with the human γ1 constant region as a putative standard for assays to detect IgG β-2glycoprotein I-dependent anticardiolipin and anti-β-2glycoprotein I antibodies"Arthritis & Rheum. 42. 2461-2470 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Wilson, W.A.: "International consensus statement on preliminary cassification criteria for definite antiphospholipid syndrome"Arthritis Rheum.. 42. 1309-1311 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Koike, T.: "Immunology of Anti-phospholipid Antibodies"Academic Press. 1051 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Koike, T.: "The Decade of Autoimmunity"Elsevier Science B.V.. 471 (1999)

    • Related Report
      1999 Annual Research Report

URL: 

Published: 1999-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi